0.06
+3.42%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Protect Pharmaceutical Corporation
Its shares trade under the ticker PRTT. It has been listed since 1 August 2006. In the fiscal year to 31 December 2024, it reported revenue of $132.3m and net income of $56.3m. At that date it held total assets of $417.6m and shareholders' equity of $332.7m.
Protect Pharmaceutical Corp. is a drug delivery and new product development company. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2006-08-01. The firm is engaged in the mineral exploration business. The firm is engaged in licensing its patented pharmaceuticals technologies. The firm's approximately 10 lode mining claims are located in Sec. 6, T2S, R1W, New Mexico Principal Meridian, of Soccorro County, New Mexico. The Claims are being held for the purpose of exploration for gold, silver and rare earth mineralization deposits, and are located near existing exploration projects. The firm has not generated any revenue.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 1 Aug 2006
- Employees
- 3
Leadership
Pay as last reported
- Mr. Alan CrooksChief Executive Officer, Director, since 2019
- Ms. Alice WilliamsTreasurer, since 2016
- Ms. Rachel WinnSecretary, since 2014
- Mr. Shimshon BandmanDirector
- Dr. Shedrick DanielsDirector
- Mr. Theodore FaisonDirector
- Mr. Stuart SandweissDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Protect Pharmaceutical Corp has a strong brand reputation in the pharmaceutical industry, known for providing high-quality and reliable healthcare products.
- The company has a robust research and development department, enabling them to continuously innovate and develop new drugs to meet market demands.
- With a well-established distribution network, Protect Pharmaceutical Corp has successfully expanded its market presence both domestically and internationally.
Weaknesses
- One of the weaknesses is high dependence on a single key supplier for certain critical raw materials, which could lead to potential supply chain disruptions.
- Protect Pharmaceutical Corp faces challenges in adapting to rapidly changing regulatory environments, which may delay the approval process for new drugs.
- The company has limited diversification in product offerings, relying heavily on a few key drug products for revenue generation.
Opportunities
- Growing demand for pharmaceutical products presents opportunities for Protect Pharmaceutical Corp to expand their market share.
- The company can explore partnerships or acquisitions to diversify its product portfolio and enter new therapeutic areas.
- Advancements in technology offer chances for Protect Pharmaceutical Corp to improve manufacturing processes, reduce costs, and enhance operational efficiency.
Threats
- Intense competition within the pharmaceutical industry poses a threat to Protect Pharmaceutical Corp's market position and profitability.
- Economic downturns or healthcare policy changes may adversely impact consumer spending on pharmaceutical products.
- Emerging market entrants with lower production costs and competitive pricing strategies could erode Protect Pharmaceutical Corp's market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.